Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
Condition(s) studied
Investigational drug(s) / intervention(s)
Tong-Xie-Yao-Fang: Tong-Xie-Yao-Fang granules were taken 2 bags at a time, 2 times per day at 1h after meal for 4 weeks.
Study summary
Traditional Chinese Medicine focuses on the main pathogenesis of liver depression and spleen deficiency, and treats them from the perspective of soothing the liver and strengthening the spleen to treat on Diarrhea-predominant irritable bowel syndrome (IBS-D) . The classic formula for treating is the Tong-Xie-Yao-Fang (TXYF). Based on metabolomics and metagenomics, the research group studied the intestinal flora and host co metabolism of TXYF in the treatment of diarrhea predominant IBS-D, in order to clarify the mechanism of TXYF in the treatment of IBS-D.
Eligibility
Primary outcome measure(s)
- Fecal metagenomic detection of bacteria associated with Trp metabolism — 16weeks
- Serum detection by Elisa — 16weeks
- Serum Trp metabolism was measured by metabolomics — 16weeks
- Th17/Treg ratio in peripheral blood was measured by flow cytometry — 16weeks
- Colon tissue was detected by immunofluorescence and histochemistry analysis — 16weeks
Foxp3 ,RORrt ,AhR ,IDO1 ,Tyn
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | Beijing | Beijing Municipality | Recruiting |
More Xiyuan Hospital of China Academy of Chinese Medical Sciences trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06737666 on ClinicalTrials.gov ↗ ← All trials in China